Literature DB >> 10741897

Biology of BCR-ABL.

R Chopra1, Q Q Pu, A G Elefanty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10741897     DOI： 10.1054/blre.1999.0119

Source DB:  PubMed          Journal:  Blood Rev        ISSN： 0268-960X            Impact factor:   8.250


× No keyword cloud information.
  7 in total

1.  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.

Authors:  Arthur R Salomon; Scott B Ficarro; Laurence M Brill; Achim Brinker; Qui T Phung; Christer Ericson; Karsten Sauer; Ansgar Brock; David M Horn; Peter G Schultz; Eric C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-09       Impact factor: 11.205

2.  Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.

Authors:  M Golam Mohi; Christina Boulton; Ting-Lei Gu; David W Sternberg; Donna Neuberg; James D Griffin; D Gary Gilliland; Benjamin G Neel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

3.  T cell survival and function requires the c-Abl tyrosine kinase.

Authors:  Isabelle Silberman; Ronit Vogt Sionov; Valentina Zuckerman; Sue Haupt; Zehavit Goldberg; Andreas Strasser; Zami S Ben-Sasson; Michal Baniyash; Anthony J Koleske; Ygal Haupt
Journal:  Cell Cycle       Date:  2008-12-23       Impact factor: 4.534

4.  Arg/Abl2 promotes invasion and attenuates proliferation of breast cancer in vivo.

Authors:  H Gil-Henn; A Patsialou; Y Wang; M S Warren; J S Condeelis; A J Koleske
Journal:  Oncogene       Date:  2012-07-09       Impact factor: 9.867

5.  A searchable cross-platform gene expression database reveals connections between drug treatments and disease.

Authors:  Gareth Williams
Journal:  BMC Genomics       Date:  2012-01-10       Impact factor: 3.969

6.  Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer.

Authors:  Xianfeng Zha; Ling Xu; Shaohua Chen; Lijian Yang; Yikai Zhang; Yuhong Lu; Zhi Yu; Bo Li; Xiuli Wu; Wenjie Zheng; Yangqiu Li
Journal:  Oncotarget       Date:  2016-12-20

Review 7.  Signaling Pathways That Regulate Normal and Aberrant Red Blood Cell Development.

Authors:  Mark C Wilkes; Aya Shibuya; Kathleen M Sakamoto
Journal:  Genes (Basel)       Date:  2021-10-19       Impact factor: 4.141
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.